SOCIUM Inc Company
SOCIUM Inc is a drug discovery and development company that uses AI technology to identify drug discovery targets in a few months. They have a portfolio of over 23 diseases, including oncology and rare diseases, and use a systems biology approach to analyze various OMICS data. Their focus is on developing first-in-class small molecules.
Connections
Founded Date:
2017-09-01
Last Funding Type:
Seed
Headquarters:
Tokyo, Tokyo, Japan
Investors Number:
1.0
Technology:
Artificial Intelligence, Biotechnology, Machine Learning, Pharmaceutical
Employee Number:
1-10
Industry:
Early Drug Development
Last Funding Date:
2018-10-12
Funding Status:
Seed
Total Funding:
260000000.0